Clinical Research and GCP Update

25

CRITICAL sponsor findings – Protocol Compliance

• The trial had not been conducted in accordance with the approved protocol as deliberate protocol waivers had been implemented and a process existed where waivers to eligibility criteria could be granted by the sponsor.

25

26

• Is it possible for a sponsor to undertake an interim analysis of data mid-way through a clinical trial for business decision purposes?

26

© Brookwood Global (Canary Ltd) 2021

13